-- 
WideMed Rises Most in Three Weeks on Canada Marketing Approval

-- B y   G w e n   A c k e r m a n
-- 
2011-10-05T11:19:13Z

-- http://www.bloomberg.com/news/2011-10-05/widemed-rises-most-in-three-weeks-on-canada-marketing-approval.html
WideMed (WDMD)  Ltd. advanced the most in
almost three weeks after it said it received approval from
 Canada  to market its Morpheus cardio-sleep analysis product.  The shares gained 8.3 percent, the biggest intraday jump
since Sept. 18, to 0.484 shekel at 12:57 p.m. in  Tel Aviv .  To contact the reporter on this story:
Gwen Ackerman in Jerusalem at 
 gackerman@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  